Showing results (1411-1420 of 25,391) with videos related to
Sort By:
Pageof 2,540
International Journal of Cancer|August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteriaNatalie Turner, Hui-Li Wong, Arnoud Templeton, et al.International Journal of Cancer|November 6, 2015
Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancerTheodora Maria Ripping, Rebecca A Hubbard, Johannes D M Otten, et al.International Journal of Cancer|November 6, 2015
Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectivesJoan Minguet, Katherine H Smith, Peter BramlageInternational Journal of Cancer|August 21, 2015
Postmenopausal hormone therapy and the risk of breast cancer in NorwayMarta Román, Solveig Sakshaug, Sidsel Graff-Iversen, et al.International Journal of Cancer|October 29, 2015
Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathwayEiji Sakai, Masaki Fukuyo, Ken Ohata, et al.International Journal of Cancer|August 23, 2015
Generation and characterization of a breast carcinoma model by PyMT overexpression in mammary epithelial cells of tree shrew, an animal close to primates in evolutionGuang-Zhe Ge, Hou-Jun Xia, Bao-Li He, et al.International Journal of Cancer|June 10, 2016
Risk for congenital anomalies in offspring of childhood, adolescent and young adult cancer survivorsViivi I Seppänen, Miia S Artama, Nea K Malila, et al.International Journal of Cancer|May 5, 2019
Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genesWenjuan Tian, Rui Bi, Yulan Ren, et al.International Journal of Cancer|May 18, 2019
Retraction: Festuccia, C., Gravina, G. L., Angelucci, A., Millimaggi, D., Muzi, P., Vicentini, C. and Bologna, M. (2005), Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro. Int. J. Cancer, 115: 630-640. https://doi.org/10.1002/ijc.20917International Journal of Cancer|May 22, 2019
Statin use and risk of liver cancer: Evidence from two population-based studiesKim Tu Tran, Úna C McMenamin, Helen G Coleman, et al.Pageof 2,540